Table I Summary of patient samples

Clinical data are provided where available. M, male; F, female, n/a, not applicable.

IdentifierDiagnosisAge of onsetAge of deathPost-mortem intervalGender
yearsyearsh
HSB 120Adenoleukodystrophy56M
CABM-BR19Adult NCL2033F
CABM-BR8Adult NCLLate 30s50sM
HSB 2356Adult NCL33408M
HSB 4165Adult NCL29536.5M
UMB 338Alexander disease6.212M
UMB 613Alexander disease147M
UMB 575Krabbe disease1.44M
CABM-BR21Late infantile NCL (CLN2)M
UMB 784Late infantile NCL (CLN2)5.34F
UMB 563Mucopolysaccharidosis IIIA11.312F
UMB 821Neuromuscular disorder, undiagnosed3.68F
HSB 238Normal controln/a43F
HSB 298Normal controln/a19M
HSB 304Normal controln/a22M
HSB 331Normal controln/a16M
HSB 712Normal controln/a16M
HSB 863Normal controln/a40M
UMB 1270Seizure disorder2222F
UMB 506Sudanophilic leukodystrophy0.45F
HSB 148Tay-Sachs disease0.61.9F
HSB 1183Unknown epilepsy0.21F
CABM-BR1Unknown NCLM
CABM-BR11Unknown NCLF
CABM-BR23Unknown NCL
CABM-BR24Unknown NCL2420.6F
CABM-BR25Unknown NCL816.5F
CABM-BR32Unknown NCLF
CABM-BR33Unknown NCL12.4F
CABM-BR34Unknown NCL7.5M
CABM-BR36Unknown NCLF
HSB 4391Unknown NCL12F
HSB 2548Variant late infantile NCL725F